Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Radiology

• Publication date

  2010-03-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1148/radiol.09091028PMID 20308454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Radiologic–pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium‐90 microspheres

  2009cited by this paper
• Advanced Segmentation Techniques for Lung Nodules, Liver Metastases, and Enlarged Lymph Nodes in CT Scans

  2009cited by this paper
• Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies

  2009cited by this paper
• Controversies in the Management of Colorectal Liver Metastases: Role of PET and PET/CT

  2009cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Radiologic measurements of tumor response to treatment: practical approaches and limitations.

  2008cited by this paper
• Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.

  2008cited by this paper
• Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

  2008cited by this paper
• Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques

  2008cited by this paper
• Semi-automated measurement of hyperdense, hypodense and heterogeneous hepatic metastasis on standard MDCT slices. Comparison of semi-automated and manual measurement of RECIST and WHO criteria

  2008cited by this paper
• Recent advances in transarterial therapy of primary and secondary liver malignancies.

  2008cited by this paper
• Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.

  2008cited by this paper
• Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases.

  2008cited by this paper
• Response evaluation of gastrointestinal stromal tumors.

  2008cited by this paper
• OncoTREAT: a software assistant for cancer therapy monitoring

  2007cited by this paper
• Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET.

  2007cited by this paper
• 18FDG-PET Evaluation Correlates Better than CT with Pathological Response in a Metastatic Colon Cancer Patient Treated with Bevacizumab-Based Therapy

  2007cited by this paper
• Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

  2007cited by this paper
• Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

  2006cited by this paper
• Positron-emission tomography and assessment of cancer therapy.

  2006cited by this paper
• Morphological segmentation and partial volume analysis for volumetry of solid pulmonary lesions in thoracic CT scans

  2006cited by this paper
• Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

  2006cited by this paper
• The impact of fluor‐18‐deoxyglucose‐positron emission tomography in the management of colorectal liver metastases

  2005cited by this paper
• Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings.

  2004cited by this paper
• Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET

  2004cited by this paper
• Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.

  2004cited by this paper
• CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.

  2002cited by this paper
• Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.

  2002cited by this paper
• Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI

  2002cited by this paper
• Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient.

  2001cited by this paper
• Tumor size on computed tomography scans

  2001cited by this paper
• Positron emission tomography and colorectal cancer

  2001cited by this paper
• A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.

  2000cited by this paper
• Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

  1999cited by this paper
• The impact of 2D versus 3D quantitation of tumor bulk determination on current methods of assessing response to treatment.

  1996cited by this paper
• The blood supply of neoplasms in the liver.

  1954cited by this paper

• Application of imaging modalities in predicting and evaluating response to anti-vascular endothelial growth factor agents and immune checkpoint inhibitors in patients with hepatocellular carcinoma

  2025cites this paper
• Focal hepatic lesions in adults-A correlative study of imaging features on Ultrasound , Triple phase Contrast Enhanced Computed Tomography , Diffusion Weighted Sequence on Magnetic Resonance Imaging with histopathological findings

  2019cites this paper
• Radioembolization of Hepatic Metastases with 90 Y-Microspheres: Indications and Procedure

  2018cites this paper
• COLORECTAL LIVER METASTASES AFTER CHEMOEMBOLIZATION WITH MICROSPHERES: PROGNOSTIC VALUE OF LESION FEATURES AND CHOICE OF THE OBJECTIVE RESPONSE CRITERIA

  2018cites this paper
• МЕТАСТАЗЫ КОЛОРЕКТАЛЬНОГО РАКА В ПЕЧЕНЬ ПОСЛЕ ХИМИОЭМБОЛИЗАЦИИ МИКРОСФЕРАМИ: ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ ЛУЧЕВЫХ ПРИЗНАКОВ ОЧАГОВ И ВЫБОР КРИТЕРИЕВ ОЦЕНКИ ОБЪЕКТИВНОГО ОТВЕТА

  2018cites this paper
• Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis

  2017cites this paper
• Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

  2016cites this paper
• Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.

  2016cites this paper
• SIRFLOX: Progression-Free Survival in the Liver As a Surrogate End Point for Survival?

  2016cites this paper
• Performance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET

  2015cites this paper
• Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.

  2015cites this paper
• The Role of 18 F-FDG-PET and PET / CT in Patients with Colorectal Liver Metastases Undergoing Selective Internal Radiation Therapy with Yttrium-90 : A First Evidence-Based Review

  2015influential citation
• The Role of 18F-FDG-PET and PET/CT in Patients with Colorectal Liver Metastases Undergoing Selective Internal Radiation Therapy with Yttrium-90: A First Evidence-Based Review

  2014influential citation
• Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer

  2014cites this paper
• [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.

  2014cites this paper
• Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.

  2014cites this paper
• Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques

  2014cites this paper
• Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.

  2014cites this paper
• Treatment of liver tumours with yttrium radioembolisation

  2014cites this paper
• Correlación radio-patológica de criterios morfológicos en la valoración de metástasis hepáticas de adenocarcinoma de colon

  2014cites this paper
• Assessment of liver tumor response to therapy: role of quantitative imaging.

  2013cites this paper
• Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Radioembolization of Liver Metastases

  2013cites this paper
• Imaging tumor response following liver-directed intra-arterial therapy

  2013cites this paper
• A radiologist's guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers.

  2013cites this paper
• EVALUATION OF TREATMENT RESPONSE AND COMPLICATIONS

  2013cites this paper
• Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response?

  2013cites this paper
• Liver Metastases in Colon Cancer

  2012cites this paper
• MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques.

  2012cites this paper
• Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.

  2012influential citation
• Hepatic tumors: region-of-interest versus volumetric analysis for quantification of attenuation at CT.

  2012cites this paper
• Response to treatment series: part 2, tumor response assessment--using new and conventional criteria.

  2011cites this paper
• Short-term evaluation of liver tumors after transarterial chemoembolization: limitations and feasibility of contrast-enhanced ultrasonography

  2011cites this paper
• New Imaging Techniques for 90 Y Microsphere Radioembolization

  2011cites this paper